New York State Common Retirement Fund’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-106,700
| Closed | -$5.6M | – | 3310 |
|
|
2020
Q3 | $5.6M | Sell |
106,700
-1,300
| -1% | -$53.8K | 0.01% | 1122 |
|
|
2020
Q2 | $3.59M | Buy |
108,000
+19,500
| +22% | +$621K | ﹤0.01% | 1286 |
|
|
2020
Q1 | $2.41M | Hold |
88,500
| – | – | ﹤0.01% | 1338 |
|
|
2019
Q4 | $1.75M | Sell |
88,500
-10,100
| -10% | -$162K | ﹤0.01% | 1683 |
|
|
2019
Q3 | $1.28M | Buy |
98,600
+500
| +0.5% | +$6.04K | ﹤0.01% | 1869 |
|
|
2019
Q2 | $1.22M | Buy |
98,100
+22,800
| +30% | +$303K | ﹤0.01% | 1917 |
|
|
2019
Q1 | $1.09M | Hold |
75,300
| – | – | ﹤0.01% | 1917 |
|
|
2018
Q4 | $831K | Sell |
75,300
-209,137
| -74% | -$2.91M | ﹤0.01% | 2019 |
|
|
2018
Q3 | $7.48M | Buy |
284,437
+3,800
| +1% | +$103K | 0.01% | 1117 |
|
|
2018
Q2 | $5.74M | Buy |
280,637
+4,900
| +2% | +$105K | 0.01% | 1217 |
|
|
2018
Q1 | $5M | Buy |
275,737
+1,000
| +0.4% | +$16.7K | 0.01% | 1234 |
|
|
2017
Q4 | $3.83M | Sell |
274,737
-11,716
| -4% | -$158K | ﹤0.01% | 1337 |
|
|
2017
Q3 | $5.3M | Hold |
286,453
| – | – | 0.01% | 1200 |
|
|
2017
Q2 | $4.84M | Buy |
286,453
+24,715
| +9% | +$376K | 0.01% | 1286 |
|
|
2017
Q1 | $3.49M | Buy |
261,738
+1
| +0% | +$16 | ﹤0.01% | 1402 |
|
|
2016
Q4 | $3.94M | Hold |
261,737
| – | – | 0.01% | 1345 |
|
|
2016
Q3 | $3.06M | Buy |
261,737
+5,300
| +2% | +$62.3K | ﹤0.01% | 1447 |
|
|
2016
Q2 | $2.77M | Buy |
256,437
+49,260
| +24% | +$508K | ﹤0.01% | 1486 |
|
|
2016
Q1 | $1.91M | Buy |
207,177
+56,186
| +37% | +$605K | ﹤0.01% | 1613 |
|
|
2015
Q4 | $2.24M | Buy |
150,991
+2,900
| +2% | +$48.5K | ﹤0.01% | 1555 |
|
|
2015
Q3 | $2.43M | Sell |
148,091
-50,403
| -25% | -$1.03M | ﹤0.01% | 1516 |
|
|
2015
Q2 | $4.53M | Buy |
198,494
+14,603
| +8% | +$291K | 0.01% | 1408 |
|
|
2015
Q1 | $2.79M | Sell |
183,891
-2,000
| -1% | -$26K | ﹤0.01% | 1510 |
|
|
2014
Q4 | $2.24M | Hold |
185,891
| – | – | ﹤0.01% | 1583 |
|
|
2014
Q3 | $2.11M | Sell |
185,891
-13,300
| -7% | -$152K | ﹤0.01% | 1601 |
|
|
2014
Q2 | $2.41M | Buy |
199,191
+68,176
| +52% | +$805K | ﹤0.01% | 1590 |
|
|
2014
Q1 | $1.53M | Buy |
131,015
+1,500
| +1% | +$25.4K | ﹤0.01% | 1738 |
|
|
2013
Q4 | $2.29M | Buy |
129,515
+25,615
| +25% | +$430K | ﹤0.01% | 1583 |
|
|
2013
Q3 | $1.5M | Hold |
103,900
| – | – | ﹤0.01% | 1655 |
|
|
2013
Q2 | $1.56M | Buy |
+103,900
| New | +$1.37M | ﹤0.01% | 1526 |
|
New York State Common Retirement Fund's MNTA Position: Q4 2020 in Review
New York State Common Retirement Fund sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 106,700 shares — an estimated $5.6M sold.
New York State Common Retirement Fund first reported a position in MNTA in Q2 2013 and held it in 30 quarters. The position peaked at $7.48M in Q3 2018. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.
- New York State Common Retirement Fund reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
- New York State Common Retirement Fund sold 106,700 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $5.6M.
- New York State Common Retirement Fund first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2013 and held it in 30 quarters.
- New York State Common Retirement Fund's Momenta Pharmaceuticals, Inc. position peaked at $7.48M in Q3 2018.
- 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.
Based on New York State Common Retirement Fund's 13F filing for Q4 2020, filed 8 Feb 2021.